ArticleCureus2025
A Case of Refractory Mycoplasma Pneumonia With Extra-pulmonary Manifestations in a Community-Acquired Setting.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case highlights a young female in her early twenties who presented with fever and persistent dry cough of one week duration. After ruling out other conditions she was subsequently diagnosed as Mycoplasma pneumonia. It is one of the important causes of atypical pneumonia. The manifestations can range from mild upper respiratory tract infections to severe pulmonary and extra-pulmonary manifestations. The patient's clinical course was complicated by systemic immune activation, which manifested as elevated inflammatory markers, radiological and clinical worsening and development of autoimmune hemolytic anemia. Prompt identification and management with appropriate antimicrobials and other supportive therapy along with timely use of steroid led to steady clinical improvement. This case underlines the importance of considering atypical pathogens in febrile respiratory illnesses and the vigilance for early recognition of systemic immune phase complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.